○Shigemasa Suzuki, Tsuyoshi Uchiyama, Tatsuhito Ishii, Hironobu Myojin, Yoshiyuki Kondo, Keishirou Satou, Toshihiko Ohashi (Department of Neurology Seirei Hamamatsu General Hospital)
Session information
[held on paper]Japanese Poster Session
[Pj-42] Japanese Poster Session 42
Neuroimmunity (multiple sclerosis 1)
○Katsuichi Miyamoto, Susumu Kusunoki (Department of Neurology, Kindai University School of Medicine)
○Yuko Shimizu (Tokyo Women`s Medical University)
[Pj-42-4] The experience of using fingolimod in the patients with multiple sclerosis in our hospital
○Mizuki Kitamura1, Takuya Sasaki1, Takahiro Nakayama1, Tomoki Nakamori2, Ichiro Imafuku1 (1.Department of Neurology, Yokohama Rosai Hospital, 2.Department of Emergency and Disaster Medicine, Emergency and Critical Care Center, Yokohama Rosai Hospital)
○Megumi Isa1, Akiko Ishii1, Yasuhiro Ogawa1, Takashi Kanbayashi2, Akira Tamaoka1 (1.University of Tsukuba hospital, Neurology, 2.International Institute for Integrative Sleep Medicine)
○Kazumasa Yokoyama1, Ryusuke Sato2, Haruki Makioka2, Michihiro Kanda2, Naoto Matsuda2, Takahiko Saida3 (1.Department of Neurology, Juntendo University School of Medicine, 2.Biogen Japan Ltd., 3.Kyoto Min-iren Central Hospital, Kansai Multiple Sclerosis Center)
○Megumi Toko1, Hiroki Ueno1, Tomohiko Ohshita1, Juri Kitamura2, Kazuhide Ochi3, Hirofumi Maruyama1 (1.Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, 2.Department of Neurology, National Hospital Organization Higashihiroshima Medical Center, 3.Department of Neurology, Hiroshima City Asa Hospital)
○Chihiro Namatame1, Tatsuro Misu1, Toshiyuki Takahashi1,2, Ryo Ogawa3, Kimihiko Kaneko1,4, Yoshiki Takai1, Shuhei Nishiyama1, Ichiro Nakashima5, Kazuo Fujihara6, Masashi Aoki1 (1.Department of Neurology, Tohoku University School of Medicine, 2.Department of Neurology, Yonezawa National Hospital, 3.Department of Neurology, Sendai City Hospital, 4.Department of Neurology, Miyagi National Hospital, 5.Department of Neurology, Tohoku Medical and Pharmaceutical University, 6.Department Multiple Sclerosis & Therapeutics, Fukushima Medical University)
○Hirofumi Ochi1, Kazumasa Yokoyama2, Ichiro Nakashima3, Ryusuke Sato4, Haruki Makioka4, Yayoi Sato4, Naoto Matsuda4, Takashi Yamamura5 (1.Department of Neurology and Geriatric Medicine, Ehime University Graduate School of Medicine, 2.Department of Neurology, Juntendo University School of Medicine, 3.Division of Neurology, Tohoku Medical and Pharmaceutical University, 4.Biogen Japan Ltd., 5.Department of Immunology, National Institute of Neuroscience, National Center of Neurology and Psychiatry)
○Ayako Koguchi, Manato Hara, Hirokazu Uchigami, Nanaka Yamaguchi, Kenichiro Sato, Kaori Sakuishi, Tatsushi Toda (The University Tokyo hospital, department of Neurology)